|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,954.00 GBX | +1.96% |
|
-0.48% | +6.88% |
| 07-15 | GSK Completes $10.6 Billion Acquisition of Nuvalent | MT |
| 07-15 | GSK completes USD10.6 billion acquisition of Nuvalent | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | +1.93% | -0.48% | +6.88% | +37.18% | +9.50% | 103B |  | |  |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
